{"slug":"wegovy-vs-ozempic-comparison-differences-similarities-2026","question":"Ozempic vs Wegovy","answer":"Ozempic and Wegovy are both semaglutide medications made by the same manufacturer, but Ozempic is FDA-approved for type 2 diabetes while Wegovy is FDA-approved for chronic weight management in non-diabetic patients. Wegovy uses higher doses (2.4 mg maximum) compared to Ozempic's typical diabetes dosing (1-2 mg), and Wegovy is marketed and priced differently despite containing the same active ingredient.","answer_curated":true,"verdict":"Choose Ozempic if you have type 2 diabetes and need better insurance coverage—it's the same medication at lower approved doses with higher likelihood of insurance reimbursement. Choose Wegovy if your primary goal is weight loss without diabetes, you're uninsured or willing to pay out-of-pocket, and you want the higher 2.4 mg dose shown to produce greater weight loss (~15% vs 5-7%). Both medications carry identical side effect profiles; the choice primarily hinges on medical indication, dosing needs, and insurance coverage status.","keyDifferences":[{"label":"FDA-Approved Indication","winner":"tie","entityAValue":"Type 2 diabetes management","entityBValue":"Chronic weight management (non-diabetic)"},{"label":"Maximum Approved Dose","winner":"b","entityAValue":"2 mg weekly","entityBValue":"2.4 mg weekly"},{"label":"Average Monthly Cost (Uninsured)","winner":"a","entityAValue":"$900-1,200","entityBValue":"$1,300-1,500"},{"label":"Insurance Coverage Likelihood","winner":"a","entityAValue":"High (diabetes is covered indication)","entityBValue":"Lower (weight loss often excluded)"},{"label":"Average Weight Loss at Max Dose","winner":"b","entityAValue":"5-7% body weight (typical diabetes use)","entityBValue":"15% body weight (clinical trial average)"}],"winner":{"slug":"ozempic","name":"Ozempic"},"confidence":"high","entities":[{"name":"Ozempic","slug":"ozempic","url":"https://www.aversusb.net/entity/ozempic","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/ozempic"},{"name":"Wegovy","slug":"wegovy","url":"https://www.aversusb.net/entity/wegovy","alternativesUrl":"https://www.aversusb.net/api/v1/alternatives/wegovy"}],"faqs":[{"question":"Can I use Ozempic off-label for weight loss if I don't have diabetes?","answer":"Yes, many physicians prescribe Ozempic off-label for weight loss in non-diabetic patients, and some insurance plans will cover it in this context (50-65% likelihood). However, this is technically an off-label use, and insurance coverage is less certain than for its FDA-approved diabetes indication. Wegovy is the FDA-approved option specifically for non-diabetic weight management, though it carries higher out-of-pocket costs and lower insurance coverage rates (10-20%)."},{"question":"Are Ozempic and Wegovy the exact same medication?","answer":"Yes, both contain identical semaglutide as the active ingredient and are manufactured by Novo Nordisk. The differences are regulatory (different FDA-approved indications), dosing (Wegovy goes up to 2.4 mg vs Ozempic's 2 mg), pricing strategy, and marketing. The pharmaceutical formulation, injection delivery, and mechanism of action are identical."},{"question":"Why is Wegovy so much more expensive than Ozempic if they're the same drug?","answer":"Wegovy costs more ($1,300-1,500/month vs $900-1,200 for Ozempic uninsured) for three reasons: (1) it's approved at a higher maximum dose (2.4 mg vs 2 mg), (2) it's marketed for weight loss rather than diabetes, so insurance coverage is lower, shifting costs to patients, and (3) manufacturers often price medications differently based on indication and reimbursement landscape. The higher dosing in Wegovy also produces greater weight loss, which justifies some price differential."}],"attribution":{"source":"A Versus B","url":"https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026","license":"CC BY 4.0","citationFormat":"According to A Versus B (https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026), Ozempic and Wegovy are both semaglutide medications made by the same manufacturer, but Ozempic is FDA-approved for type 2 diabetes while Wegovy is FDA-approved for chronic weight management in non-dia","dateModified":"2026-06-20T18:01:50.528Z"},"relatedQuestionsUrl":"https://www.aversusb.net/api/faq/wegovy-vs-ozempic-comparison-differences-similarities-2026","relatedComparisonsUrl":"https://www.aversusb.net/api/v1/related/wegovy-vs-ozempic-comparison-differences-similarities-2026","knowledgeGraphUrl":"https://www.aversusb.net/api/knowledge-graph/wegovy-vs-ozempic-comparison-differences-similarities-2026","claimReviewSchema":{"@context":"https://schema.org","@type":"ClaimReview","@id":"https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026#claimreview","url":"https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026","inLanguage":"en-US","isAccessibleForFree":true,"conditionsOfAccess":"Free","claimReviewed":"Ozempic vs Wegovy","reviewBody":"Ozempic and Wegovy are both semaglutide medications made by the same manufacturer, but Ozempic is FDA-approved for type 2 diabetes while Wegovy is FDA-approved for chronic weight management in non-diabetic patients. Wegovy uses higher doses (2.4 mg maximum) compared to Ozempic's typical diabetes dosing (1-2 mg), and Wegovy is marketed and priced differently despite containing the same active ingredient.","datePublished":"2026-03-27T14:30:22.474Z","dateModified":"2026-06-20T18:01:50.528Z","reviewRating":{"@type":"Rating","ratingValue":5,"worstRating":1,"bestRating":5,"alternateName":"High Confidence"},"author":{"@type":"Organization","@id":"https://www.aversusb.net/#organization","name":"A Versus B","url":"https://www.aversusb.net"},"itemReviewed":{"@type":"WebPage","@id":"https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026","url":"https://www.aversusb.net/compare/wegovy-vs-ozempic-comparison-differences-similarities-2026","name":"Ozempic vs Wegovy","inLanguage":"en-US"}}}